Compare Hilton Hotels Corporation Common Stock (HLT) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hilton Hotels Corporation Common Stock vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Hilton Hotels Corporation Common Stock trades at $323.19 (market cap $72.76B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B). The key difference: Hilton Hotels Corporation Common Stock is far larger — about 2.9× Royalty Pharma plc Class A Ordinary Shares's market cap, and Royalty Pharma plc Class A Ordinary Shares pays the higher dividend (1.66%). Which is the better fit depends on your goals — on Pluang, investors hold Hilton Hotels Corporation Common Stock for 138 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| HLT | RPRX | |
|---|---|---|
Market Cap | $72.76B | $25.27B |
Volume | 1,148,634 | 3,671,183 |
Sector | Consumer Cyclical | Health |
52-Week High | $350.22 | $63.96 |
52-Week Low | $256.96 | $35.44 |
Typical Hold Time | 138 Days | 0 Days |
Enterprise Value | $85.78B | $32.50B |
Dividend Yield | 0.19% | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hilton Worldwide (HLT) trades at $320.50, down 0.65% on the day, with strong technical momentum showing a bullish moving average signal. The company demonstrates consistent revenue growth, reaching $12.04 billion in 2025, with earnings beating expectations for three consecutive quarters. Analyst sentiment remains overwhelmingly positive with 57% buy ratings and a $348.11 consensus price target representing 8.6% upside potential. Recent institutional buying activity and upcoming Q3 2026 earnings on October 27 provide near-term catalysts.
Hilton presents a compelling investment case with robust fundamentals and positive momentum, though elevated valuation metrics (P/E of 47.07) and increasing debt levels warrant caution. The stock's technical positioning near key support at $318 suggests potential for continued upward movement if earnings momentum persists, while institutional accumulation and strong travel demand support the bullish thesis.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Hilton Hotels Corporation Common Stock
Hilton Worldwide Holdings operates 1,074,791 rooms across its 18 brands addressing the midscale through luxury segments as of Dec. 31, 2021. Hampton and Hilton are the two largest brands by total room count at 28% and 21%, respectively, as of Dec. 31, 2021. Recent brands launched over the last few years include Home2, Curio, Canopy, Tru, and Tempo. Managed and franchised represent the vast majority of adjusted EBITDA, predominantly from the Americas regions.
Read more on HLT →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
